首页> 美国卫生研究院文献>Cardiology Research and Practice >Mortality Trends in Patients Hospitalized with the Initial Acute Myocardial Infarction in a Middle Eastern Country over 20 Years
【2h】

Mortality Trends in Patients Hospitalized with the Initial Acute Myocardial Infarction in a Middle Eastern Country over 20 Years

机译:中东国家20年来最初住院的急性心肌梗死患者的死亡率趋势

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We aimed to define the temporal trend in the initial Acute Myocardial Infarction (AMI) management and outcome during the last two decades in a Middle Eastern country. A total of 10,915 patients were admitted with initial AMI with mean age of 53 ± 11.8 years. Comparing the two decades (1991–2000) to (2001–2010), the use of antiplatelet drugs increased from 84% to 95%, β-blockers increased from 38% to 56%, and angiotensin converting enzyme inhibitors (ACEI) increased from 12% to 36% (P < 0.001 for all). The rates of PCI increased from 2.5% to 14.6% and thrombolytic therapy decreased from 71% to 65% (P < 0.001 for all). While the rate of hospitalization with Initial MI increased from 34% to 66%, and the average length of hospital stay decreased from 6.4 ± 3 to 4.6 ± 3, all hospital outcomes parameters improved significantly including a 39% reduction in in-hospital Mortality. Multivariate logistic regression analysis showed that higher utilization of antiplatelet drugs, β-blockers, and ACEI were the main contributors to better hospital outcomes. Over the study period, there was a significant increase in the hospitalization rate in patients presenting with initial AMI. Evidence-based medical therapies appear to be associated with a substantial improvement in outcome and in-hospital mortality.
机译:我们的目标是定义一个中东国家最近二十年来初始急性心肌梗死(AMI)管理和结果的时间趋势。共有10,915例初次AMI患者入院,平均年龄为53±11.8岁。将这两个十年(1991–2000年)与(2001–2010年)进行比较,抗血小板药物的使用率从84%增加到95%,β受体阻滞剂从38%增加到56%,而血管紧张素转换酶抑制剂(ACEI)从12%至36%(所有P均<0.001)。 PCI的发生率从2.5%增加到14.6%,溶栓治疗从71%下降到65%(所有P均<0.001)。虽然初始MI的住院率从34%增加到66%,平均住院时间从6.4±3减少到4.6±3,但所有医院结局指标均得到显着改善,包括住院死亡率降低了39%。多元logistic回归分析显示,更高的抗血小板药物,β受体阻滞剂和ACEI利用率是改善医院预后的主要因素。在研究期间,初次出现AMI的患者的住院率显着增加。循证医学疗法似乎与预后和院内死亡率的大幅提高有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号